Cytochrome P450 Epoxygenase CYP2J2 G-50T Polymorphism is an Independent Genetic Prognostic Risk Factor and Interacts with Smoking Cessation After Index Premature Myocardial Infarction

QR Code

Cytochrome P450 Epoxygenase CYP2J2 G-50T Polymorphism is an Independent Genetic Prognostic Risk Factor and Interacts with Smoking Cessation After Index Premature Myocardial Infarction

None

Saved in:

Bibliographic Details
Main Authors:	Liu, Ping-Yen, Li, Yi-Heng, Chen, Jyh-Hong
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/29905
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Isoform CYP1A2, as a part of the cytochrome P450 superfamily
by: Y. G. Novickaya, et al.
Published: (2014-04-01)

Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
by: O. G. Gribakina, et al.
Published: (2020-04-01)

Tropoxine in the effective dose does not affect on activity of CYP2С9 and CYP1А2 isoforms of cytochrome P450 in rats
by: V. P. Zherdev, et al.
Published: (2017-11-01)

Effects of Smoking and Smoking Cessation and Smoking Cessation Intervention
by: Hanioka, T., et al.
Published: (2012)

Evaluation of the relationship between cytochrome P450 (CYP) 1A2 gene copy number variation and CYP1A2 protein content and enzyme activity in canine liver
by: Francisco Gonzales Zamora, et al.
Published: (2025-07-01)

Activities of cytochrome P450 enzyme CYP102A16 from Bacillus sp. C3
by: LI Ze-li, et al.
Published: (2012-11-01)

Cytochrome P450 CYP76F14 Mediates the Conversion of Its Substrate Linalool in Table Grape Berries
by: Zhizhong Song, et al.
Published: (2025-06-01)

Involvement of the cytochrome P450 genes CYP6DW3 and CYP4C64 in afidopyropen resistance in Bemisia tabaci Mediterranean (Q biotype)
by: Lijun Ma, et al.
Published: (2025-05-01)

SMOKING CESSATION COUNSELLING
by: D. M. Maksimov
Published: (2018-10-01)

Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms
by: O. G. Gribakina, et al.
Published: (2019-02-01)

Cytochrome P450 Enzyme Inhibitors from Nature
by: Badal, Simone, et al.
Published: (2012)

BACTERIAL CYTOCHROME P-450: II. STRUCTURE AND FUNCTIONS
by: Б. М. Галкін, et al.
Published: (2010-12-01)

CYTOCHROME P-450s: I. GENERAL AND EVOLUTIONARY ASPECTS
by: Б. М. Галкін, et al.
Published: (2010-09-01)

The Cytochrome CYP4 in Breast and Other Cancers
by: Gloria M. Calaf, et al.
Published: (2025-07-01)

HETEROLOGOUS EXPRESSION OF RECOMBINANT MOUSE CYTOCHROME P450 2E1 IN ESCHERICHIA COLI
by: В. Н. Заец, et al.
Published: (2012-06-01)

CYP2C9*2 and CYP2C9*3 allele variants of CYP2C9 cytochrome gene in St. Petersburg population, and their clinical role in warfarin anticoagulant therapy
by: O. V. Sirotkina, et al.
Published: (2004-12-01)

Pharmacological regulation of the activity of cytochrome P450 3A4 AND P450 2C9 isoenzymes by vitamins and natural compounds
by: E. V. Shikh, et al.
Published: (2018-02-01)

Characteristics and roles of cytochrome b5 in cytochrome P450-mediated oxidative reactions in Locusta migratoria
by: Jiao LIU, et al.
Published: (2020-06-01)

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN
by: O. V. Guzeva, et al.
Published: (2016-05-01)

A STUDY OF GENETIC POLYMORPHISMS OF CYTOCHROME P450 CYP 2D6 IN PATIENTS WITH CORONARY HEART DISEASE COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TAKING A BETA-BLOCKER
by: T. E. Morozova, et al.
Published: (2013-12-01)

Do Cytochrome P450 Enzymes Contribute to the Metabolism of Xenobiotics in Human?
by: Abass, Khaled, et al.
Published: (2010)

Determination of Cytochrome P450 Metabolic Activity Using Selective Markers
by: Jurica, Jan, et al.
Published: (2012)

The Role of Anopheles gambiae P450 Cytochrome in Insecticide Resistance and Infection
by: Félix, Rute, et al.
Published: (2012)

The cytochrome P450 superfamily: Key players in plant development and defense
by: Jun XU, et al.
Published: (2015-09-01)

CYTOCHROME P450 (CYP2C9) ACTIVENESS, EVALUATED VIA LOSARTAN TEST, AS PREDICTION MARKER FOR THE WARFARIN TREATMENT DOSAGE CHOICE IN PATIENTS WITH DELAYED OUTCOMES AFTER HEART VALVES REPLACEMENT
by: S. M. Arslanbekova, et al.
Published: (2015-10-01)

The impact of cigarette smoking and smoking cessation on risk and phenotype of rheumatoid arthritis
by: E. G. Zotkin, et al.
Published: (2024-12-01)

Genetic and Epigenetic Factors Affecting Cytochrome P450 Phenotype and Their Clinical Relevance
by: Tamási, Viola, et al.
Published: (2012)

Transcription Factors Potentially Involved in Regulation of Cytochrome P450 Gene Expression
by: Czekaj, Piotr, et al.
Published: (2012)

Metabolism of Pyrethroids by Mosquito Cytochrome P450 Enzymes: Impact on Vector Control
by: Rongnoparut, Pornpimol, et al.
Published: (2012)

Response of Cytochrome P450 Expression to Maize Volatiles in Helicoverpa armigera (Hübner)
by: Shao-ying WU, et al.
Published: (2013-04-01)

Medical care for smoking cessation in general practitioners’ practice
by: M. V. Vershinina, et al.
Published: (2021-06-01)

Cytochrome P-450 3A4 system in patients with acute myocardial infarction
by: A. G. Vladimirov, et al.
Published: (2008-08-01)

SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking
by: O. D. Ostroumova, et al.
Published: (2018-03-01)

The Effect of Cytochrome P450 and Organic Anion Transporter Polypeptide on Macrolides–Atorvastatin Drug Interaction
by: Zainab Farooq Abdalhameed, et al.
Published: (2025-06-01)

Cytochrome P450-catalyzed allylic oxidation of pentalenene to 1-deoxypentalenic acid in pentalenolactone biosynthesis
by: Jing Li, et al.
Published: (2025-06-01)

Inhibition of Cytochrome P450 Activities by Propoxazepam: Safety Assessment in Context for Potential Drug Interactions
by: Віталій Ларіонов, et al.
Published: (2025-02-01)

The ILE462VAL polymorphism of the cytochrome P450 CYP1A1 gene among Tundra Nenets in Yamalo-Nenets Autonomous Okrug, Nganasans in the Taimyr Peninsula and Russians in Siberia
by: R. P. Tiis, et al.
Published: (2016-03-01)

Targeted but Troubling: CYP450 Inhibition by Kinase and PARP Inhibitors and Its Clinical Implications
by: Martin Kondža, et al.
Published: (2025-05-01)

Molecular characterization and expression profiles of cytochrome P450 reductase gene in Sogatella furcifera (Hemiptera: Delphacidae)
by: YU Hang, et al.
Published: (2016-07-01)

FREQUENCIES OF POLYMORPHISMS IN THE CYTOCHROME’S P450 GENES OF WARFARIN TRANSFORMATION IN A EUROPEAN POPULATION OF EASTERN SIBERIA
by: T. A. Bairova, et al.
Published: (2018-09-01)